S1119 Peruvian H. Pylori Water Contamination Study

Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment

NCT02988089 ·Status: UNKNOWN ·Phase: PHASE4

Helicobacter Pylori First-line Treatment Containing Tetracycline in Patients Allergic to Penicillin

NCT05129176 ·Status: UNKNOWN ·Phase: PHASE4

Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication

NCT02557932 ·Status: COMPLETED ·Phase: PHASE3

Helicobacter Pylori Infection and Gastric Disease in Bhutan: First Community-Wide, Population-Based Study

NCT07211880 ·Status: COMPLETED ·Phase: NA

Development of Treatment Algorithm for Eradication of Helicobacter Pylori Based on Antibiotic Susceptibility Test

NCT02759029 ·Status: UNKNOWN ·Phase: NA

Efficacy and Safety of Dual Therapy as First-line Treatment for Hp Infection

NCT05419674 ·Status: UNKNOWN ·Phase: PHASE4

Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori Infection

NCT03516669 ·Status: COMPLETED ·Phase: PHASE4

Study of Pylopass Versus Placebo in Subjects Who Are Helicobacter Pylori Carriers and With Mild Indigestion

NCT02051348 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Eradication Rates of Helicobacter Pylori and Its Affecting Factors

NCT01922505 ·Status: COMPLETED

New Strategy for the Detection and Treatment of Helicobacter Pylori Infections in Primary Care Guided by a Non-invasive PCR in Stool

NCT05495854 ·Status: TERMINATED ·Phase: NA

Modified Non-clarithromycin Triple Therapy in Eradicating Helicobacter Pylori

NCT02776371 ·Status: COMPLETED ·Phase: PHASE4

Tailored Vs. Empirical Helicobacter Pylori Infection Treatment

NCT06200779 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection

NCT05718609 ·Status: UNKNOWN ·Phase: PHASE4

Eradication of H. Pylori Therapy Individualized by the Mutation of 23S rRNA of H. Pylori

NCT02761005 ·Status: UNKNOWN ·Phase: PHASE2

S0701, Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori (H. Pylori)

NCT01061437 ·Status: COMPLETED ·Phase: PHASE3

The Efficacy of Quadruple Therapy Containing Sodium Bicarbonate as the Primary Treatment for Helicobacter Pylori Infection

NCT06591494 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

Efficacy of Different Acid Suppressors in Bismuth-containing Quadruple Therapy Against Helicobacter Pylori

NCT05301725 ·Status: COMPLETED

A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile

NCT05926804 ·Status: RECRUITING ·Phase: NA

Helicobacter Pylori Eradication Rates of Bismuth-containing Quadruple Therapy vs Modified Quadruple Therapy in Korea

NCT03665428 ·Status: COMPLETED ·Phase: PHASE4

Helicobacter Pylori First-line Treatment in Patients Allergic to Penicillin

NCT04122287 ·Status: UNKNOWN ·Phase: PHASE4

Prospective Study : Helicobacter Pylori Eradication Therapy in Accordance With Past Antibiotics Use

NCT01938534 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy of a 14-Day Bismuth-Containing Quadruple Therapy Guided by Drug Susceptibility Testing in Patients with Extremely Refractory Helicobacter Pylori Infection: an Exploratory Study

NCT06731023 ·Status: NOT_YET_RECRUITING

The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection

NCT05620602 ·Status: UNKNOWN

Helicobacter Pylori Infection and Gastric Diseases in Lao PDR: First Community-Wide Population-Based Study

NCT07340593 ·Status: COMPLETED

The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication

NCT04527055 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4